Literature DB >> 2831119

Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.

H W Verspaget1, A S Peña, I T Weterman, C B Lamers.   

Abstract

Features of the neutrophil oxidative metabolism and enzyme activity in peripheral blood neutrophils were studied in 43 patients with Crohn's disease, 13 with ulcerative colitis and 33 healthy controls. The production of superoxide anion (O2-.) by phorbol-myristate-acetate stimulated neutrophils from patients with Crohn's disease and ulcerative colitis was significantly diminished compared with controls mean (SE) = 47.1 (3.6) and 38.0 (3.8) v 67.4 (7.5) nmol/10(7) cells/min, p less than or equal to 0.02, respectively, while the production of hydrogen peroxide was normal. The neutrophil content of superoxide dismutase (SOD), a cytoprotective enzyme, was also markedly diminished in Crohn's disease mean (SE) = 7.11 (0.23) ng SOD/micrograms DNA, p less than 0.05, and ulcerative colitis mean (SE) = 5.74 (0.42) compared with controls 7.84 (0.27), p less than 0.001. In contrast, the concentration of neutrophil elastase, a neutral protease, was found to be normal when compared with neutrophils from controls. The neutrophil O2-. production and the SOD concentrations were significantly and negatively correlated with the disease activity in Crohn's disease and ulcerative colitis. The results indicate diminished neutrophil function in peripheral blood of patients with Crohn's disease and ulcerative colitis as illustrated by a diminished oxidative system, which correlates with the disease activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831119      PMCID: PMC1433298          DOI: 10.1136/gut.29.2.223

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

2.  Oxygen-dependent microbial killing by phagocytes (second of two parts).

Authors:  B M Babior
Journal:  N Engl J Med       Date:  1978-03-30       Impact factor: 91.245

3.  Improvements in the ethidium bromide method for direct fluorometric estimation of DNA and RNA in cell and tissue homogenates.

Authors:  U Karsten; A Wollenberger
Journal:  Anal Biochem       Date:  1977-02       Impact factor: 3.365

4.  Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease.

Authors:  C O Moráin; A A Segal; D Walker; A J Levi
Journal:  Gut       Date:  1981-10       Impact factor: 23.059

5.  Orgotein: a new anti-inflammatory metalloprotein drug: preliminary evaluation of clinical efficacy and safety in degenerative joint disease.

Authors:  K Lund-Olesen; K B Menander
Journal:  Curr Ther Res Clin Exp       Date:  1974-07

6.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

7.  Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.

Authors:  Y Miyachi; A Yoshioka; S Imamura; Y Niwa
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

8.  Free radicals and inflammation: protection of synovial fluid by superoxide dismutase.

Authors:  J M McCord
Journal:  Science       Date:  1974-08-09       Impact factor: 47.728

9.  Superoxide dismutase and glutathione peroxidase in polymorphonuclear leucocytes.

Authors:  M Rister; K Bauermeister; U Gravert; E Gladtke
Journal:  Eur J Pediatr       Date:  1979-02-08       Impact factor: 3.183

10.  alpha 1-Antitrypsin-levels and phenotypes in Crohn's disease in the Netherlands.

Authors:  E C Klasen; I Biemond; I T Weterman
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

View more
  33 in total

Review 1.  Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease.

Authors:  J R Korzenik; B K Dieckgraefe
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

Review 2.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Resveratrol suppresses colitis and colon cancer associated with colitis.

Authors:  Xiangli Cui; Yu Jin; Anne B Hofseth; Edsel Pena; Joshua Habiger; Alexander Chumanevich; Deepak Poudyal; Mitzi Nagarkatti; Prakash S Nagarkatti; Udai P Singh; Lorne J Hofseth
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-23

4.  Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats.

Authors:  C Loguercio; G D'Argenio; M Delle Cave; V Cosenza; N Della Valle; G Mazzacca; C del Vecchio Blanco
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 5.  Clinical relevance of oxygen radicals in inflammatory bowel disease--facts and fashion.

Authors:  H Allgayer
Journal:  Klin Wochenschr       Date:  1991-12-15

6.  Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease.

Authors:  J G Williams; L E Hughes; M B Hallett
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

Review 7.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

8.  The effects of caffeic acid phenethyl ester (CAPE) on TNBS-induced colitis in ovariectomized rats.

Authors:  Rauf Onur Ek; Mukadder Serter; Kemal Ergin; Yuksel Yildiz; Serpil Cecen; Tulay Kavak; Cigdem Yenisey
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

9.  Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.

Authors:  T P Mulder; H W Verspaget; A R Janssens; P A de Bruin; A S Peña; C B Lamers
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

10.  Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells.

Authors:  P J Mannon; F Leon; I J Fuss; B A Walter; M Begnami; M Quezado; Z Yang; C Yi; C Groden; J Friend; R L Hornung; M Brown; S Gurprasad; B Kelsall; W Strober
Journal:  Clin Exp Immunol       Date:  2008-12-15       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.